Al Ti Global, Inc. Neurocrine Biosciences Inc Transaction History
Al Ti Global, Inc.
- $3.81 Trillion
- Q1 2025
A detailed history of Al Ti Global, Inc. transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Al Ti Global, Inc. holds 6,757 shares of NBIX stock, worth $855,098. This represents 0.02% of its overall portfolio holdings.
Number of Shares
6,757
Previous 5,086
32.85%
Holding current value
$855,098
Previous $729 Million
2.57%
% of portfolio
0.02%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding NBIX
# of Institutions
649Shares Held
97.1MCall Options Held
749KPut Options Held
553K-
Black Rock Inc. New York, NY14.2MShares$1.8 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.94MShares$1.26 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.53MShares$700 Million0.37% of portfolio
-
State Street Corp Boston, MA4.86MShares$615 Million0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY2.67MShares$338 Million0.02% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $12.1B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...